.webp)
Clinical manufacturing is the production of drug substances and drug products under strictly controlled conditions for use in clinical trials. It ensures that experimental therapies meet rigorous quality, safety, and regulatory standards before they are tested in humans. Many pharmaceutical developers partner with a pharmaceutical CDMO to access specialized expertise, state-of-the-art facilities, and experience in the efficient and consistent production of clinical materials.
Jan 19, 2026
.webp)
Small molecule drugs are low-molecular-weight compounds that can readily enter cells to modulate biological processes. They form the foundation of many treatments across therapeutic areas, including cardiovascular and metabolic diseases, oncology, and infectious diseases. Their relatively simple structure, compared to that of biologics, allows for oral administration, easier formulation, and cost-effective production. Understanding small molecule development is critical for companies aiming to deliver effective therapies efficiently.
Jan 16, 2026
.webp)
Lyophilization, also known as freeze-drying, is a critical technology for improving the stability and shelf life of drug products, including biologics and other complex modalities. Many drug substances that demonstrate strong biological activity struggle to remain stable in solution long enough to meet the 24-month shelf life typically required for commercial viability. Lyophilization addresses this challenge by converting liquid formulations into dry, solid products that can be stored and transported under refrigerated conditions rather than frozen, reducing logistical complexity.
Jan 14, 2026
.webp)
Flow chemistry scale-up has become an increasingly important focus in modern drug development programs. Compared to traditional batch processing, flow chemistry offers advantages in speed, safety, process control, and sustainability. Although these benefits are well-documented, many organizations struggle to fully realize them. The challenge is often not adopting flow chemistry in the lab but scaling the process efficiently as molecules move toward clinical and commercial manufacturing.
Jan 13, 2026
.webp)
The pharmaceutical industry relies on dependable API manufacturing services to ensure that drug products reach patients safely and on time. Disruptions in the supply chain – whether from natural disasters, regulatory issues, or global crises – can delay production and impact patient care. Many companies address these risks by partnering with CDMOs that implement business continuity management (BCM) strategies to ensure supply from development through commercialization.
Jan 12, 2026
.png)
.webp)
.webp)
.webp)
.webp)
.png)
.webp)
.png)
.png)
.png)
.webp)
.png)
.png)
.webp)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
-1.png)
-1.png)
-1.png)
.png)
.png)
.png)
.png)
-1.png)
.png)
.png)
.png)
